Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss, Sensorineural | 1 | 2021 | 16 | 0.740 |
Why?
|
| Thrombocytopenia | 1 | 2021 | 31 | 0.740 |
Why?
|
| Brain Neoplasms | 3 | 2006 | 133 | 0.320 |
Why?
|
| Mutation | 3 | 2021 | 409 | 0.310 |
Why?
|
| Cardiac Output, High | 1 | 2004 | 1 | 0.230 |
Why?
|
| Teratoma | 1 | 2004 | 5 | 0.230 |
Why?
|
| Fetal Diseases | 1 | 2004 | 7 | 0.230 |
Why?
|
| Platelet Count | 1 | 2021 | 22 | 0.190 |
Why?
|
| Blood Platelets | 1 | 2021 | 51 | 0.190 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2018 | 2 | 0.160 |
Why?
|
| Genes, Recessive | 1 | 2018 | 9 | 0.160 |
Why?
|
| Spectrin | 1 | 2018 | 3 | 0.160 |
Why?
|
| Epidural Abscess | 1 | 2016 | 7 | 0.130 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2016 | 19 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 464 | 0.130 |
Why?
|
| Spinal Cord Compression | 1 | 2016 | 31 | 0.130 |
Why?
|
| Skull Base Neoplasms | 1 | 2014 | 17 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 2 | 2006 | 271 | 0.110 |
Why?
|
| Humans | 14 | 2021 | 30997 | 0.110 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2006 | 337 | 0.100 |
Why?
|
| Epstein-Barr Virus Infections | 2 | 2010 | 19 | 0.100 |
Why?
|
| Female | 7 | 2021 | 16983 | 0.100 |
Why?
|
| Plasmacytoma | 1 | 2011 | 19 | 0.100 |
Why?
|
| Multiple Myeloma | 1 | 2011 | 29 | 0.090 |
Why?
|
| Smooth Muscle Tumor | 1 | 2010 | 2 | 0.090 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2011 | 61 | 0.080 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 2006 | 4 | 0.070 |
Why?
|
| Myeloproliferative Disorders | 1 | 2006 | 5 | 0.070 |
Why?
|
| Neural Tube Defects | 1 | 2006 | 9 | 0.070 |
Why?
|
| Vascular Neoplasms | 1 | 2006 | 4 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2006 | 33 | 0.070 |
Why?
|
| Central Nervous System | 1 | 2006 | 56 | 0.070 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 1 | 2004 | 2 | 0.060 |
Why?
|
| Panniculitis | 1 | 2004 | 4 | 0.060 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2004 | 9 | 0.060 |
Why?
|
| Hydroxychloroquine | 1 | 2004 | 9 | 0.060 |
Why?
|
| Anemia, Sideroblastic | 1 | 2004 | 1 | 0.060 |
Why?
|
| Oxazolidinones | 1 | 2004 | 6 | 0.060 |
Why?
|
| Acetamides | 1 | 2004 | 7 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 2004 | 23 | 0.060 |
Why?
|
| Prognosis | 2 | 2018 | 919 | 0.060 |
Why?
|
| Anti-Infective Agents | 1 | 2004 | 63 | 0.060 |
Why?
|
| Lymphomatoid Granulomatosis | 1 | 2003 | 3 | 0.060 |
Why?
|
| Skull | 1 | 2004 | 26 | 0.060 |
Why?
|
| Head | 1 | 2004 | 27 | 0.060 |
Why?
|
| Edema | 1 | 2004 | 40 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2003 | 69 | 0.050 |
Why?
|
| Lymphoma, T-Cell | 1 | 2002 | 6 | 0.050 |
Why?
|
| Staphylococcal Infections | 1 | 2004 | 185 | 0.050 |
Why?
|
| Male | 7 | 2018 | 16445 | 0.050 |
Why?
|
| Kidney Transplantation | 1 | 2002 | 126 | 0.050 |
Why?
|
| Aged | 5 | 2011 | 10048 | 0.040 |
Why?
|
| Infant | 1 | 2018 | 578 | 0.030 |
Why?
|
| Organ Transplantation | 1 | 2016 | 39 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2010 | 430 | 0.030 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2006 | 39 | 0.030 |
Why?
|
| Rituximab | 2 | 2006 | 55 | 0.030 |
Why?
|
| Remission Induction | 2 | 2006 | 105 | 0.030 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2014 | 7 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 407 | 0.030 |
Why?
|
| Decompression, Surgical | 1 | 2016 | 151 | 0.030 |
Why?
|
| Adult | 4 | 2014 | 8931 | 0.030 |
Why?
|
| Middle Aged | 3 | 2016 | 10195 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2011 | 64 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2011 | 81 | 0.020 |
Why?
|
| Skin | 1 | 2011 | 124 | 0.020 |
Why?
|
| Sarcoma, Kaposi | 1 | 2010 | 5 | 0.020 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2010 | 46 | 0.020 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2010 | 93 | 0.020 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2010 | 131 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 260 | 0.020 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2006 | 3 | 0.020 |
Why?
|
| Karyotyping | 1 | 2006 | 11 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 817 | 0.020 |
Why?
|
| Janus Kinase 2 | 1 | 2006 | 2 | 0.020 |
Why?
|
| ras Proteins | 1 | 2006 | 11 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 60 | 0.020 |
Why?
|
| DNA | 1 | 2006 | 124 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 2006 | 9 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2006 | 190 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2006 | 3806 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 442 | 0.020 |
Why?
|
| Recurrence | 1 | 2006 | 370 | 0.020 |
Why?
|
| Nuclear Envelope | 1 | 2004 | 4 | 0.020 |
Why?
|
| Antimalarials | 1 | 2004 | 9 | 0.020 |
Why?
|
| Linezolid | 1 | 2004 | 6 | 0.020 |
Why?
|
| Staphylococcus epidermidis | 1 | 2004 | 5 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2004 | 15 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 583 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2004 | 67 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2004 | 36 | 0.010 |
Why?
|
| Antigens, CD20 | 1 | 2003 | 5 | 0.010 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2003 | 9 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2003 | 14 | 0.010 |
Why?
|
| Vincristine | 1 | 2003 | 27 | 0.010 |
Why?
|
| Cranial Irradiation | 1 | 2003 | 13 | 0.010 |
Why?
|
| Vision Disorders | 1 | 2003 | 23 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 2003 | 58 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2003 | 46 | 0.010 |
Why?
|
| Methotrexate | 1 | 2003 | 43 | 0.010 |
Why?
|
| Prednisone | 1 | 2003 | 69 | 0.010 |
Why?
|
| Doxorubicin | 1 | 2003 | 70 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2003 | 386 | 0.010 |
Why?
|
| Pleural Effusion | 1 | 2002 | 12 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 105 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2003 | 195 | 0.010 |
Why?
|
| Prosthesis-Related Infections | 1 | 2004 | 222 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2002 | 121 | 0.010 |
Why?
|
| Liver | 1 | 2002 | 184 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2002 | 217 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 1311 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 691 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 5189 | 0.010 |
Why?
|